55 results
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
15 May 24
Condensed consolidated interim financial statements
6:02am
31, 2024 (2023 – loss of $206,950). The fair value was determined using the Black-Scholes option pricing model and the following assumptions … . The Company determined the fair value of the services received could not be measured reliably and determined the fair value using the Black-Scholes model
6-K
EX-99.1
HUGE
FSD Pharma Inc - Ordinary Shares
15 Nov 23
Condensed consolidated interim financial statements
12:00am
) and $113,211 for the three and nine months ended September 30, 2023. The fair value was determined using the Black-Scholes option pricing model … value using the Black-Scholes model.
FSD PHARMA INC.
Notes to the condensed consolidated interim financial statements
(expressed in United States
6-K
EX-99.2
9d3yc8aymvqvellw
15 Nov 23
Condensed consolidated interim financial statements
12:00am
6-K
EX-99.2
7u06wme236 gx483fuf3
20 Jul 23
Condensed consolidated interim financial statements
5:05pm
6-K
EX-99.1
4eoo6fq
20 Jul 23
Condensed consolidated interim financial statements
5:05pm
6-K
EX-99.1
i4d18
12 May 23
Condensed consolidated interim financial statements
6:55pm
6-K
EX-99.2
q8u7 eby1vcllmyl
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.1
x6nn9
14 Nov 22
Condensed consolidated interim financial statements
6:02am
6-K
EX-99.1
561eq
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.2
2o1oe02 1n23iwf3
12 Aug 22
Condensed consolidated interim financial statements
4:58pm
6-K
EX-99.1
v0uwpj46
23 May 22
Annual General Meeting of the Shareholders
4:29pm
6-K
EX-99.1
zdiqeg7wuffr3v0zc4d
13 May 22
Condensed consolidated interim financial statements
5:10pm
6-K
EX-99.2
i8uthdu
13 May 22
Condensed consolidated interim financial statements
5:10pm
20-F
60gf5t0532t
31 Mar 22
Annual report (foreign)
8:09am
20-F
EX-15.1
79vvq5btlbdjqj2up5oa
31 Mar 22
Annual report (foreign)
8:09am